October 2, 2025
Hitachi, Ltd.
Hitachi, Ltd. ("Hitachi") will join the "Cell & Gene Meeting on the Mesa," one of the world's leading annual international conferences in the field of cell and gene therapy as a Gold Sponsor, to be held from October 6 to 8, 2025, in Phoenix, Arizona, U.S.
The "Cell & Gene Meeting on the Mesa" brings together top executives and decision-makers from across the industry to engage in wide-ranging discussions—from cutting-edge research findings to solutions for challenges on the path to commercialization. At this event, Hitachi group will introduce products and solutions that integrate its advanced technologies in measurement, AI, and automation for the cell and gene therapy field.
Hitachi has identified biopharmaceuticals and gene and cell therapies as strategic growth areas. And Hitachi is committed to strengthening its global presence through the "One Hitachi" approach by advancing the digitalization and efficiency of drug discovery and manufacturing processes. Looking ahead, Hitachi aims to contribute to enhancing people’s well-being through the clinical and commercial progress of these innovative therapies, in collaboration with global partners. By leveraging data from a robust installed base of products in these fields (digitalized assets), combined with deep domain knowledge and advanced AI, Hitachi will continue to drive the evolution of Lumada*1 3.0 to address the challenges faced by customers and society.
